Pages that link to "Q80548343"

The following pages link to Vaccination of patients with advanced non-small-cell lung cancer with an optimized cryptic human telomerase reverse transcriptase peptide (Q80548343):

Displaying 38 items.

• Optimized tumor cryptic peptides: the basis for universal neo-antigen-like tumor vaccines (Q26738680) (← links)
• Therapeutic Targeting of Telomerase (Q26741736) (← links)
• Telomere and Telomerase Therapeutics in Cancer (Q26744808) (← links)
• Upregulated human telomerase reverse transcriptase (hTERT) expression is associated with spinal chordoma growth, invasion and poor prognosis (Q33276030) (← links)
• Chemistry in human telomere biology: structure, function and targeting of telomere DNA/RNA (Q33814333) (← links)
• RFPL3 and CBP synergistically upregulate hTERT activity and promote lung cancer growth (Q34044752) (← links)
• The role of telomeres and telomerase in hematologic malignancies and hematopoietic stem cell transplantation (Q34544862) (← links)
• Therapeutic cancer vaccines: are we there yet? (Q34786691) (← links)
• TCR hypervariable regions expressed by T cells that respond to effective tumor vaccines (Q36137249) (← links)
• Augmenting antitumor T-cell responses to mimotope vaccination by boosting with native tumor antigens (Q36510860) (← links)
• Prospects and challenges of building a cancer vaccine targeting telomerase (Q36918394) (← links)
• In vitro activation of hTERT-specific T cell responses in lung cancer patients following chemotherapy (Q36972928) (← links)
• Telomerase and cancer therapeutics (Q37078833) (← links)
• Shortcomings of current therapies for non-small-cell lung cancer: unmet medical needs (Q37579650) (← links)
• Epstein-Barr virus and telomerase: from cell immortalization to therapy (Q37619108) (← links)
• Immunotherapy in the landscape of new targeted treatments for non-small cell lung cancer (Q37619114) (← links)
• Vaccination with poly(IC:LC) and peptide-pulsed autologous dendritic cells in patients with pancreatic cancer. (Q37741161) (← links)
• Telomerase and the endocrine system (Q37859251) (← links)
• Novel anticancer therapeutics targeting telomerase (Q38030204) (← links)
• New targets for the immunotherapy of colon cancer-does reactive disease hold the answer? (Q38089480) (← links)
• Lung cancer: potential targets for immunotherapy (Q38181691) (← links)
• A second chance for telomerase reverse transcriptase in anticancer immunotherapy (Q38849194) (← links)
• Antitumor effects of telomerase inhibitor TMPyP4 in osteosarcoma cell lines (Q39540587) (← links)
• Immunogenicity of a recombinant lentiviral vector carrying human telomerase tumor antigen in HLA-B*0702 transgenic mice (Q39676680) (← links)
• Immunotherapy as a strategy for the treatment of non-small-cell lung cancer (Q41878129) (← links)
• Antigen-based therapy for the treatment of type 1 diabetes (Q42057025) (← links)
• Trial Watch: Peptide vaccines in cancer therapy (Q42734544) (← links)
• Telomerase Peptide Vaccination Combined with Temozolomide: A Clinical Trial in Stage IV Melanoma Patients (Q43786937) (← links)
• Telomerase based anticancer immunotherapy and vaccines approaches (Q50147673) (← links)
• Myeloid dendritic cells loaded with dendritic tandem multiple antigenic telomerase reverse transcriptase (hTERT) epitope peptides: A potentially promising tumor vaccine (Q53175501) (← links)
• Clinical outcome of patients with various advanced cancer types vaccinated with an optimized cryptic human telomerase reverse transcriptase (TERT) peptide: results of an expanded phase II study (Q54565078) (← links)
• Immunological responses in cancer patients after vaccination with the therapeutic telomerase-specific vaccine Vx-001 (Q54566447) (← links)
• Telomerase-Targeted Cancer Immunotherapy (Q64252676) (← links)
• Naturally occurring tumor-specific CD8 T-cell precursors in individuals with and without cancer (Q82835695) (← links)
• Pilot Study of 1650-G: A Simplified Cellular Vaccine for Lung Cancer (Q82849202) (← links)
• A phase I study of personalized peptide vaccination using 14 kinds of vaccine in combination with low‐dose estramustine in HLA‐A24‐positive patients with castration‐resistant prostate cancer (Q85107660) (← links)
• Clinical activity of a htert (vx-001) cancer vaccine as post-chemotherapy maintenance immunotherapy in patients with stage IV non-small cell lung cancer: final results of a randomised phase 2 clinical trial (Q90634126) (← links)
• Efficient induction of cytotoxic T lymphocytes in hepatocellular carcinoma using the HLA-A2-restricted survivin peptide in vitro (Q91414382) (← links)